Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTP-499 in Type 2 Diabetic Nephropathy
NCT01487109Phase 2Completed
- Sponsor
- Concert Pharmaceuticals
- Start
- Jan 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PCS-499 in diabetic nephropathy (DN), sponsored by Concert Pharmaceuticals. Started Jan 2012; status: completed.
02
Drugs
PCS-499
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01487109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487109.